Blockchain Registration Transaction Record

GeoVax CEO to Discuss Innovative Cancer Therapies at ROTH Healthcare Conference

GeoVax Labs, Inc. CEO to join panel on cancer therapies at ROTH Healthcare Conference. The company's lead clinical program involves a next-generation COVID-19 vaccine and a gene-directed therapy for advanced head and neck cancers.

GeoVax CEO to Discuss Innovative Cancer Therapies at ROTH Healthcare Conference

This news matters as it highlights GeoVax Labs, Inc.'s efforts in developing novel vaccines for infectious diseases and therapies for solid tumor cancers, including a next-generation COVID-19 vaccine and a gene-directed therapy for advanced head and neck cancers. The participation of their CEO in the panel discussion signifies the company's commitment to advancing innovative treatments for life-threatening diseases.

BlockchainDetails
Contract Address0x0553B273B8eBf464Bd2a37C259F0eEBb3d70Fd71
Transaction ID0xb70ec34065cdf5bd3f8941dbfdae7e4d79192ae7444f3edc3a5e5092352b2eb3
Account0xdBdE7c76e403a5923F3dD4F050Dbbf5c2077BB20
Chainpolygon-main
NewsRamp Digital Fingerprintlarkwsll-c30ffafc7322c0d0a30d2da6cad587a0